DeepMed Research

VANDERBILT UNIVERSITY MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1925-01-01

Employees: 10K

Market Cap: -

Website: http://www.vumc.org

Clinical Trials

Pancreatic Enzyme Replacement and Glucose Regulation in Type 1 Diabetes

Early Phase 1

Completed

Conditions: Type 1 Diabetes

Interventions: Drug: Placebo
Drug: CREON

First Posted Date: 2022-03-04

Last Posted Date: 2025-03-28

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 11

Registration Number: NCT05266963

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Pragmatic Trial Examining Oxygenation Prior to Intubation

Not Applicable

Completed

Conditions: Acute Respiratory Failure

Interventions: Other: Facemask Oxygen
Other: Preoxygenation with Non-Invasive Positive Pressure Ventilation

First Posted Date: 2022-03-04

Last Posted Date: 2024-12-09

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 1301

Registration Number: NCT05267652

Locations: 🇺🇸
University of Wisconsin-Madison, Madison, Wisconsin, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Hennepin County Medical Center, Minneapolis, Minnesota, United States

and more 13 locations

Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)

Phase 2

Recruiting

Conditions: Asthma

Interventions: Other: Placebo
Drug: Semaglutide Pen Injector 2.4mg weekly

First Posted Date: 2022-02-24

Last Posted Date: 2025-02-20

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 100

Registration Number: NCT05254314

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease

Phase 2

Completed

Conditions: Chronic Kidney Diseases

Interventions: Drug: dulaglutide injection

First Posted Date: 2022-02-24

Last Posted Date: 2025-04-20

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 7

Registration Number: NCT05254418

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

DirEct Versus VIdeo LaryngosCopE Trial

Not Applicable

Completed

Conditions: Acute Respiratory Failure

Interventions: Other: Video Laryngoscope
Other: Direct Laryngoscope

First Posted Date: 2022-02-14

Last Posted Date: 2024-08-19

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 1420

Registration Number: NCT05239195

Locations: 🇺🇸
Ochsner Medical Center | Ochsner Health System, New Orleans, Louisiana, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Harborview Medical Center, Seattle, Washington, United States

and more 9 locations

Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition

Phase 2

Active, not recruiting

Conditions: Down Syndrome
Down Syndrome, Partial Trisomy 21
Alzheimer Disease

Interventions: Drug: [18F]-FEOBV Radiotracer

First Posted Date: 2022-02-09

Last Posted Date: 2025-03-11

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 20

Registration Number: NCT05231798

Locations: 🇺🇸
Vanderbilt University Medical Center Clinical Research Center, Nashville, Tennessee, United States

High Vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients

Phase 2

Recruiting

Conditions: Influenza
Transplantation Infection
Immunization; Infection

Interventions: Biological: Standard Dose Quadrivalent Inactivated Influenza Vaccine
Biological: High Dose Quadrivalent Inactivated Influenza Vaccine

First Posted Date: 2022-01-31

Last Posted Date: 2024-11-04

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 270

Registration Number: NCT05215327

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 3

Phase 1

Completed

Conditions: Diabetes Mellitus, Type 2

Interventions: Drug: L-Lysine
Drug: Normal Saline

First Posted Date: 2022-01-27

Last Posted Date: 2024-06-05

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 23

Registration Number: NCT05210504

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Intraoperative Optical Coherence Tomography for Ophthalmic Surgical Guidance - Cornea

Not yet recruiting

Conditions: Corneal Transplantation

First Posted Date: 2022-01-27

Last Posted Date: 2025-05-21

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 24

Registration Number: NCT05210478

Locations: 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States

Prospective Phenotyping for Genetic Subtypes of Early-onset Atrial Fibrillation

Recruiting

Conditions: Atrial Fibrillation

Interventions: Other: None/Observational Studies

First Posted Date: 2022-01-13

Last Posted Date: 2025-05-11

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 225

Registration Number: NCT05190679

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy